353 related articles for article (PubMed ID: 34801416)
1. Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran.
Zare H; Rezapour H; Mahmoodzadeh S; Fereidouni M
Int Immunopharmacol; 2021 Dec; 101(Pt B):108351. PubMed ID: 34801416
[TBL] [Abstract][Full Text] [Related]
2. Side effects of Sputnik V, Oxford-AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran.
Oghazian S; Tavanaei Tamanaei T; Haghighi R; Faregh M; Oghazian MB
Int Immunopharmacol; 2023 Apr; 117():109784. PubMed ID: 36812676
[TBL] [Abstract][Full Text] [Related]
3. Short-term side effects of COVID-19 vaccines among healthcare workers: a multicenter study in Iran.
Mirnia K; Haji Esmaeil Memar E; Kamran N; Yeganedoost S; Nickhah Klashami Z; Mamishi S; Mahmoudi S
Sci Rep; 2024 Feb; 14(1):4086. PubMed ID: 38374372
[TBL] [Abstract][Full Text] [Related]
4. Analysis and comparison of anti-RBD neutralizing antibodies from AZD-1222, Sputnik V, Sinopharm and Covaxin vaccines and its relationship with gender among health care workers.
Zare H; Rezapour H; Fereidouni A; Nikpour S; Mahmoudzadeh S; Royce SG; Fereidouni M
Immun Ageing; 2022 Oct; 19(1):47. PubMed ID: 36273175
[TBL] [Abstract][Full Text] [Related]
5. Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran.
Babamahmoodi F; Saeedi M; Alizadeh-Navaei R; Hedayatizadeh-Omran A; Mousavi SA; Ovaise G; Kordi S; Akbari Z; Azordeh M; Ahangarkani F; Alikhani A
Sci Rep; 2021 Nov; 11(1):21464. PubMed ID: 34728696
[TBL] [Abstract][Full Text] [Related]
6. Potential Adverse Effects of COVID-19 Vaccines on Iranian Healthcare Workers: Comparison of Four Available Vaccines in Tehran: A Retrospective Cross-sectional Study.
Abdollahi A; Naseh I; Kalroozi F; Kazemi-Galougahi MH; Nezamzadeh M; Qorbanzadeh A; Ameri R; Taghavi H; Zoshk MY
Oman Med J; 2023 Mar; 38(2):e486. PubMed ID: 37168286
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of response to different COVID-19 vaccines in vaccinated healthcare workers in a single center in Iran.
Pourakbari B; Mirbeyk M; Mahmoudi S; Hosseinpour Sadeghi RH; Rezaei N; Ghasemi R; Esfandiari F; Mamishi S
J Med Virol; 2022 Dec; 94(12):5669-5677. PubMed ID: 35883215
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects following COVID-19 vaccination in Iran.
Babaee E; Amirkafi A; Tehrani-Banihashemi A; SoleimanvandiAzar N; Eshrati B; Rampisheh Z; Asadi-Aliabadi M; Nojomi M
BMC Infect Dis; 2022 May; 22(1):476. PubMed ID: 35585518
[TBL] [Abstract][Full Text] [Related]
9. Personalized predictions of adverse side effects of the COVID-19 vaccines.
Jamshidi E; Asgary A; Kharrazi AY; Tavakoli N; Zali A; Mehrazi M; Jamshidi M; Farrokhi B; Maher A; von Garnier C; Rahi SJ; Mansouri N
Heliyon; 2023 Jan; 9(1):e12753. PubMed ID: 36597482
[TBL] [Abstract][Full Text] [Related]
10. Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system.
Enayatrad M; Mahdavi S; Aliyari R; Sahab-Negah S; Nili S; Fereidouni M; Mangolian Shahrbabaki P; Ansari-Moghaddam A; Heidarzadeh A; Shahraki-Sanavi F; Fateh M; Khajeha H; Emamian Z; Behmanesh E; Sheibani H; Abbaszadeh M; Jafari R; Valikhani M; Binesh E; Vahedi H; Chaman R; Sharifi H; Emamian MH
BMC Infect Dis; 2023 Mar; 23(1):150. PubMed ID: 36899326
[TBL] [Abstract][Full Text] [Related]
11. Short-term Side Effects of COVID-19 Vaccines (Astrazeneca, Sputnik-V, and Sinopharm) in Health Care Workers: A Cross-Sectional Study in Iran.
Azimi-Nezhad M; Gholami A; Taghiabadi E; Ghodsi H
Med J Islam Repub Iran; 2022; 36():159. PubMed ID: 36721491
[No Abstract] [Full Text] [Related]
12. Covid-19 Vaccines Available in India.
Mukim M; Sharma P; Patweker M; Patweker F; Kukkar R; Patel R
Comb Chem High Throughput Screen; 2022; 25(14):2391-2397. PubMed ID: 35293291
[TBL] [Abstract][Full Text] [Related]
13. Side effects of COVID-19 vaccines among Iranian healthcare workers: a retrospective cohort study.
Roudgari H; Etemad K; Karami M; Mostafavi F; Sotoodeh Ghorbani S; Farhadi Babadi K; Rahimi E; Taherpour N; Fattahi Masoom SM; Habibi M; Kermanpour H; Laripour R; Manoochehri O; Raeeszadeh M; Salimi A; Shekarchi B; Tajernia A; Zafarghandi MR; Zali A; Zarghi A; Hashemi Nazari SS
J Infect Dev Ctries; 2024 Apr; 18(4):532-541. PubMed ID: 38728645
[TBL] [Abstract][Full Text] [Related]
14. Headache following vaccination against COVID-19 among healthcare workers with a history of COVID-19 infection: a cross-sectional study in Iran with a meta-analytic review of the literature.
Nasergivehchi S; Togha M; Jafari E; Sheikhvatan M; Shahamati D
Head Face Med; 2023 May; 19(1):19. PubMed ID: 37202794
[TBL] [Abstract][Full Text] [Related]
15. Mild Adverse Events of Sputnik V Vaccine in Russia: Social Media Content Analysis of Telegram via Deep Learning.
Jarynowski A; Semenov A; Kamiński M; Belik V
J Med Internet Res; 2021 Nov; 23(11):e30529. PubMed ID: 34662291
[TBL] [Abstract][Full Text] [Related]
16. Side Effects Comparison of Coronavirus Vaccines Among Healthcare Workers in Shoushtar, Iran.
Nabizadeh E; Honarmandpour F; Mashhadizade R; Honarmandpour A
Clin Pathol; 2023; 16():2632010X231166798. PubMed ID: 37155553
[TBL] [Abstract][Full Text] [Related]
17. Safety of COVID-19 vaccines.
Al Khames Aga QA; Alkhaffaf WH; Hatem TH; Nassir KF; Batineh Y; Dahham AT; Shaban D; Al Khames Aga LA; Agha MYR; Traqchi M
J Med Virol; 2021 Dec; 93(12):6588-6594. PubMed ID: 34270094
[TBL] [Abstract][Full Text] [Related]
18. Sputnik V vaccine-related complications and its impression on inflammatory biomarkers in healthcare providers.
Akrami M; Hosamirudsari H; Faraji N; Behnush B; Goudarzi F; Hesari E; Akbarpour S; Najafi A; Nateghi S
Indian J Med Microbiol; 2023; 43():79-84. PubMed ID: 36357266
[TBL] [Abstract][Full Text] [Related]
19. Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms.
Kadali RAK; Janagama R; Peruru S; Gajula V; Madathala RR; Chennaiahgari N; Malayala SV
J Med Virol; 2021 Jul; 93(7):4420-4429. PubMed ID: 33822361
[TBL] [Abstract][Full Text] [Related]
20. A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran.
Soltani S; Matin BK; Gouya MM; Zahraei SM; Moradi G; Chehri O; Soofi M; Moradinazar M; Shadmani FK; Kalantari M; Khajeha H; Emamian MH; Najafi F
BMC Public Health; 2023 Jul; 23(1):1415. PubMed ID: 37488541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
